Elevated sAPPα levels in AD would also decrease the processing of APP via the amyloidogenic pathway by allosteric inhibition of BACE1, the β-secretase responsible for the generation of Aβ (Obregon et al., 2012; Peters-Libeu et al., 2015). The gene discussed is BACE1; the disease is Alzheimer disease.